Efficiency of subconjunctival bevacizumab on pterygium
Background: To evaluate the effect and complications of subconjunctival bevacizumab (Avastin ®) on primary and recurrent pterygium. Methods: This prospective study included sixteen patients with pterygium, who received subconjunctival injection of bevacizumab (1.25 mg/0,1 mL). Digital photo...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2012-06-01
|
Series: | Zdravniški Vestnik |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/934 |